Innoviva (INVA) Receivables - Other (2010 - 2025)
Innoviva (INVA) posted Receivables - Other of -$2.6 million for Q3 2025, down 143.17% on a QoQ basis from $6.1 million in Q2 2025, and up 71.22% year-over-year from -$1.5 million in Q3 2024.
Innoviva (INVA) Receivables - Other (2010 - 2025) Analysis & Trends
Innoviva's Receivables - Other history runs 16 years deep, the most recent figure standing at -$2.6 million for Q3 2025.
- Quarterly Receivables - Other rose 71.22% year-over-year to -$2.6 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$10.4 million (down 12.82% YoY) and the FY2024 annual result came in at -$3.6 million, down 124.4% from the prior year.
- Receivables - Other was -$2.6 million for Q3 2025 at Innoviva, down from $6.1 million in the prior quarter.
- Across five years, Receivables - Other topped out at $111.7 million in Q2 2022 and bottomed at -$9.1 million in Q3 2024.
- A 5-year average of $27.9 million and a median of $5.5 million in 2023 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2021 — Receivables - Other jumped 2285.85% — and 2024, when it sank 489.11%.
- Innoviva's Receivables - Other stood at $42.5 million in 2021, then slumped by 105.61% to -$2.4 million in 2022, then soared by 198.16% to $2.3 million in 2023, then sank by 489.11% to -$9.1 million in 2024, then jumped by 71.22% to -$2.6 million in 2025.
- Business Quant data shows INVA's Receivables - Other at -$2.6 million in Q3 2025, $6.1 million in Q2 2025, and -$4.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2.62 Mn |
| Sep 30, 2025 | -2.62 Mn |
| Jun 30, 2025 | 6.07 Mn |
| Jun 30, 2025 | 6.07 Mn |
| Mar 31, 2025 | -4.71 Mn |
| Mar 31, 2025 | -4.71 Mn |
| Sep 30, 2024 | -9.11 Mn |
| Sep 30, 2024 | -9.11 Mn |
| Jun 30, 2024 | 5.33 Mn |
| Jun 30, 2024 | 5.33 Mn |
| Mar 31, 2024 | -7.75 Mn |
| Mar 31, 2024 | -7.75 Mn |
| Sep 30, 2023 | 2.34 Mn |
| Sep 30, 2023 | 2.34 Mn |
| Jun 30, 2023 | 5.41 Mn |
| Jun 30, 2023 | 5.41 Mn |
| Mar 31, 2023 | 5.64 Mn |
| Mar 31, 2023 | 5.64 Mn |
| Sep 30, 2022 | -2.39 Mn |
| Sep 30, 2022 | -2.39 Mn |